Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Recruiting Observational Study
Interstitial Lung Disease (ILD) Idiopathic Pulmonary Fibrosis (IPF) Progressive Pulmonary Fibrosis Connective Tissue Disease-Associated Interstitial Lung Disease Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Hospital de Granollers · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The OXISITE-ILD study is a prospective, multicenter, observational study designed to evaluate the agreement between finger (digital) and earlobe (auricular) pulse oximetry for measuring oxygen saturation (SpO2) during the six-minute walk test (6MWT) in patients with interstitial lung disease (ILD). In routine clinical practice, exercise SpO2 is usually measured at the finger; however, the finger r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years or older * Confirmed diagnosis of interstitial lung disease (ILD) based on clinical, radiological and/or histological criteria * Newly diagnosed or under follow-up for ILD * Physically and cognitively able to perform the 6-minute walk test (6MWT) * Signed …
Contacts

Jaume Bordas-Martinez, Ph.D.; M.D.

938 42 50 00

jbordas@fphag.org

CONTACT